Tower Research Capital (TRC)’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.1K Buy
5,973
+3,827
+178% +$94K ﹤0.01% 2206
2025
Q4
$61.3K Sell
2,146
-977
-31% -$26.5K ﹤0.01% 2277
2025
Q3
$92K Sell
3,123
-2,174
-41% -$59.4K ﹤0.01% 2058
2025
Q2
$153K Buy
5,297
+4,727
+829% +$140K ﹤0.01% 2033
2025
Q1
$19.9K Buy
570
+174
+44% +$7.1K ﹤0.01% 2975
2024
Q4
$17.6K Sell
396
-2,401
-86% -$98.2K ﹤0.01% 3295
2024
Q3
$128K Sell
2,797
-78,020
-97% -$3.16M ﹤0.01% 2035
2024
Q2
$2.68M Buy
80,817
+77,700
+2,493% +$3.18M 0.05% 339
2024
Q1
$149K Sell
3,117
-9,245
-75% -$539K ﹤0.01% 1597
2023
Q4
$911K Buy
12,362
+10,137
+456% +$685K 0.01% 913
2023
Q3
$163K Sell
2,225
-11,436
-84% -$913K 0.01% 1577
2023
Q2
$1.13M Buy
13,661
+11,600
+563% +$1.02M 0.04% 439
2023
Q1
$184K Sell
2,061
-768
-27% -$66.8K 0.01% 1415
2022
Q4
$243K Buy
2,829
+595
+27% +$50.4K 0.01% 1182
2022
Q3
$160K Sell
2,234
-8,756
-80% -$783K ﹤0.01% 2140
2022
Q2
$1.07M Buy
10,990
+2,824
+35% +$288K 0.02% 649
2022
Q1
$919K Buy
8,166
+2,704
+50% +$288K 0.01% 825
2021
Q4
$738K Buy
5,462
+3,317
+155% +$462K 0.01% 870
2021
Q3
$303K Sell
2,145
-310
-13% -$41.7K 0.01% 1398
2021
Q2
$315K Sell
2,455
-2,348
-49% -$276K 0.01% 1568
2021
Q1
$614K Buy
4,803
+2,352
+96% +$434K 0.01% 1067
2020
Q4
$440K Sell
2,451
-3,622
-60% -$805K 0.01% 1089
2020
Q3
$1.33M Sell
6,073
-1,772
-23% -$395K 0.01% 710
2020
Q2
$1.76M Buy
+7,845
New +$1.23M 0.07% 267
2019
Q4
Sell
-49
Closed -$3K 4211
2019
Q3
$3K Sell
49
-540
-92% -$32.5K ﹤0.01% 3581
2019
Q2
$35K Buy
589
+386
+190% +$23.2K ﹤0.01% 1815
2019
Q1
$13K Buy
+203
New +$12.3K ﹤0.01% 2535
2018
Q3
Sell
-39
Closed -$3K 4158
2018
Q2
$3K Buy
+39
New +$2.36K ﹤0.01% 3248
2018
Q1
Sell
-199
Closed -$9K 3724
2017
Q4
$9K Sell
199
-1,092
-85% -$44.6K ﹤0.01% 2619
2017
Q3
$57K Buy
+1,291
New +$44.9K ﹤0.01% 1841
2017
Q1
Sell
-100
Closed -$2K 3745
2016
Q4
$2K Sell
100
-1,813
-95% -$38.9K ﹤0.01% 3449
2016
Q3
$42K Buy
1,913
+345
+22% +$7.37K ﹤0.01% 1237
2016
Q2
$28K Buy
+1,568
New +$27.1K ﹤0.01% 1979
2015
Q4
Sell
-3,267
Closed -$62K 4942
2015
Q3
$62K Buy
3,267
+589
+22% +$12.6K 0.01% 872
2015
Q2
$61K Buy
+2,678
New +$62.4K 0.01% 1210
2015
Q1
Sell
-3,337
Closed -$97K 4825
2014
Q4
$97K Buy
3,337
+2,464
+282% +$66.8K 0.01% 683
2014
Q3
$23K Buy
873
+440
+102% +$10.5K ﹤0.01% 2190
2014
Q2
$9K Sell
433
-24
-5% -$552 ﹤0.01% 2450
2014
Q1
$12K Sell
457
-259
-36% -$7.56K ﹤0.01% 2437
2013
Q4
$22K Sell
716
-141
-16% -$3.62K ﹤0.01% 2227
2013
Q3
$24K Buy
+857
New +$23.4K ﹤0.01% 2544

Other funds holding QDEL

Tower Research Capital (TRC)'s QDEL Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its QuidelOrtho (QDEL) stake by 178% in Q1 2026, buying an estimated $94K and bringing the position to 5,973 shares worth $98.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

Tower Research Capital (TRC) first reported a position in QDEL in Q3 2013 and has held it in 41 quarters since. The position peaked at $2.68M in Q2 2024. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Tower Research Capital (TRC) held 5,973 shares of QuidelOrtho worth $98.1K as of Q1 2026.
  • Tower Research Capital (TRC) bought 3,827 QuidelOrtho shares in Q1 2026, an estimated $94K.
  • QuidelOrtho made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2206 holding.
  • Tower Research Capital (TRC) first reported a position in QuidelOrtho in Q3 2013 and has held it in 41 quarters since.
  • Tower Research Capital (TRC)'s QuidelOrtho position peaked at $2.68M in Q2 2024.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.